NCT06448195View on ClinicalTrials.gov

Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Growth Hormone Treatment
Interventions
DRUG

Polyethylene Glycol Somatropin (rDNA origin) Injection

Specification: 54IU/9.0mg/1.0ml/ bottle Dosage form: injection; Dose: 1mg/ week. Subcutaneous injection (upper arm, thigh or abdomen periumbilical) for a total course of 6 months, a total of 3 bottles per patient

Trial Locations (1)

200032

RECRUITING

Shanghai Zhongshan Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER